Portfolio update – CADENT
The Board of International Biotechnology Trust plc (the "Company") notes that today a definitive agreement has been signed by Align Technology, Inc (NASDAQ:ALGN) to buy the portfolio company Cadent Holdings Inc.("Cadent") for $190m.
Published on 30th March 2011
/ibt.ams3.digitaloceanspaces.com%2FScience-background-with-molecule-or-atom-Abstract-structure-for-Science-or-medical-background.jpeg)